ArticleHaemophilia : the official journal of the World Federation of Hemophilia
Accuracy of Factor VIII Assays for Measuring Damoctocog Alfa Pegol: A Comparative Analysis.
Article in Haemophilia : the official journal of the World Federation of Hemophilia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionAccurate monitoring of treatment with modified factor VIII products remains challenging, due to known variability in assay performance across different laboratory methods and reagents. For the extended half-life product Damoctocog alfa pegol discrepancies have been reported.
aimsThis multicentre field study was designed to evaluate the analytical accuracy of Damoctocog alfa pegol using various methods for one-stage clotting and chromogenic assays.
methodsThe study was conducted under conditions closely mimicking routine laboratory settings. Five plasma samples were spiked with varying concentrations of Damoctocog alfa pegol (0.05 to 1.3 IU/ml) and distributed to 118 participating laboratories. FVIII activity of the samples was analysed using 12 one-stage and 7 chromogenic methods. Accuracy results were evaluated per specific reagent with a maximal acceptable mean bias of 20% from the target. Interlaboratory variation was established for reagents with ≥3 participants.
resultsThe reliability of factor VIII measurements differ between the tested reagents. Usage of SynthasIL and Pathromtin (one stage) and Biophen (chromogenic) is in most cases reliable, although inter-lab variation contributes to inaccuracy. The reagents STA PTT A and Triniclot (one stage), as well as Siemens (chromogenic) (strongly) underestimate FVIII activity and are therefore unsuitable for accurate measurement of Damoctocog alfa pegol.
conclusionWe have evaluated accuracy results for 19 Factor VIII assays in order to provide evidence-based guidance for clinical laboratories in selecting appropriate assay methodologies for reliable quantification of the activity of Damoctocog alfa pegol. Assay performance should be locally validated as large interlaboratory variation is observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.